AKT1 and breast carcinoma: Interestingly, upregulation of downstream signalling molecules, such as p42/44 mitogen-activated protein kinase (MAPK) and protein kinase B (AKT), is also an indication of endocrine resistance of breast cancer cells (Knowlden et al. 2003).